Su Zhen 4
4 · Karyopharm Therapeutics Inc. · Filed May 30, 2024
Insider Transaction Report
Form 4
Su Zhen
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2024-05-29+50,587→ 50,587 totalExercise: $0.96Exp: 2034-05-28→ Common Stock (50,587 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on May 29, 2025.